Colonic Gallstone Ileus, Diagnostic-therapeutic Algorithm
Launched by TOMISLAV BRUKETA · Jul 4, 2021
Trial Information
Current as of May 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all published cases and case series with a complete description of colonic gallstone ileus
- Exclusion Criteria:
- • small bowel gallstone ileus; gastric outlet gallstone ileus; non-gallstone intraluminal obstruction; and cholecystocolonic fistula without colonic gallstone ileus
About Tomislav Bruketa
Tomislav Bruketa is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, Bruketa leads initiatives that emphasize safety, efficacy, and ethical standards in clinical trials. His collaborative approach involves partnerships with research institutions, healthcare professionals, and regulatory bodies to ensure the seamless execution of studies across various therapeutic areas. By fostering an environment of transparency and accountability, Tomislav Bruketa is poised to contribute significantly to the evolving landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagreb, , Croatia
Patients applied
Trial Officials
Goran Augustin, M.D., Ph.D
Study Director
Clinical Hospital Centre Zagreb
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials